Danish life science foundations broke investment records in 2021

Some of Denmark’s most powerful funds, many of which have links to the pharmaceutical industry, broke one record after another in 2021. This provides opportunities, respective CEOs of the Novo Nordisk Foundation, William Demant Invest and the Lundbeck Foundation say.
Lene Skole, CEO of the Lundbeck Foundation | Photo: Gregers Tycho/ERH
Lene Skole, CEO of the Lundbeck Foundation | Photo: Gregers Tycho/ERH
by benjamin werner christiansen, translated by catherine brett

After a historically strong 2021, some of Denmark’s most powerful funds have record capital at their disposal.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading